|
1
|
Schwartz DA, Loftus EV Jr, Tremaine WJ,
Panaccione R, Harmsen WS, Zinsmeister AR and Sandborn WJ: The
natural history of fistulizing Crohn's disease in Olmsted County,
Minnesota. Gastroenterology. 122:875–880. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
American Gastroenterological Association
Clinical Practice Committee, . American Gastroenterological
Association medical position statement: Perianal Crohn's disease.
Gastroenterology. 125:1503–1507. 2003.PubMed/NCBI
|
|
3
|
Lapidus A: Crohn's disease in Stockholm
County during 1990–2001: An epidemiological update. World J
Gastroenterol. 12:75–81. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tang LY, Rawsthorne P and Bernstein CN:
Are perineal and luminal fistulas associated in Crohn's disease? A
population-based study. Clin Gastroenterol Hepatol. 4:1130–1134.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Peyrin-Biroulet L, Loftus EV Jr, Colombel
JF and Sandborn WJ: The natural history of adult Crohn's disease in
population-based cohorts. Am J Gastroenterol. 105:289–297. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bouguen G, Siproudhis L, Gizard E,
Wallenhorst T, Billioud V, Bretagne JF, Bigard MA and
Peyrin-Biroulet L: Long-term outcome of perianal fistulizing
Crohn's disease treated with infliximab. Clin Gastroenterol
Hepatol. 11:975–981. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mizrahi N, Wexner SD, Zmora O, Da Silva G,
Efron J, Weiss EG, Vernava AM III and Nogueras JJ: Endorectal
advancement flap: Are there predictors of failure? Dis Colon
Rectum. 45:1616–1621. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sonoda T, Hull T, Piedmonte MR and Fazio
VW: Outcomes of primary repair of anorectal and rectovaginal
fistulas using the endorectal advancement flap. Dis Colon Rectum.
45:1622–1628. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Löffler T, Welsch T, Mühl S, Hinz U,
Schmidt J and Kienle P: Long-term success rate after surgical
treatment of anorectal and rectovaginal fistulas in Crohn's
disease. Int J Colorectal Dis. 24:521–526. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schwandner O: Video-assisted anal fistula
treatment (VAAFT) combined with advancement flap repair in Crohn's
disease. Tech Coloproctol. 17:221–225. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ingle SB and Loftus EV Jr: The natural
history of perianal Crohn's disease. Dig Liver Dis. 39:963–969.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mahadev S, Young JM, Selby W and Solomon
MJ: Quality of life in perianal Crohn's disease: What do patients
consider important? Dis Colon Rectum. 54:579–585. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yamamoto T, Allan RN and Keighley MR:
Effect of fecal diversion alone on perianal Crohn's disease. World
J Surg. 24:1258–1263. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bernstein CN, Fried M, Krabshuis JH, Cohen
H, Eliakim R, Fedail S, Gearry R, Goh KL, Hamid S, Khan AG, et al:
World Gastroenterology Organization Practice Guidelines for the
diagnosis and management of IBD in 2010. Inflamm Bowel Dis.
16:112–124. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sandborn WJ, Fazio VW, Feagan BG and
Hanauer SB: American Gastroenterological Association Clinical
Practice Committee: AGA technical review on perianal Crohn's
disease. Gastroenterology. 125:1508–1530. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
The Chinese Medical Association Digestion
of Neurology IBEG, . The consensus on diagnosis and management of
inflammatory bowel disease (Guangzhou, 2012). Zhonghua Nei Ke Za
Zhi. 2012:818–831. 2012.(In Chinese).
|
|
17
|
Gecse KB, Bemelman W, Kamm MA, Stoker J,
Khanna R, Ng SC, Panés J, van Assche G, Liu Z, Hart A, et al: World
Gastroenterology Organization, International Organisation for
Inflammatory Bowel Diseases IOIBD and European Society of
Coloproctology and Robarts Clinical Trials: A global consensus on
the classification, diagnosis and multidisciplinary treatment of
perianal fistulising Crohn's disease. Gut. 63:1381–1392. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang J, Liao C, Wu L, Cao Y and Gao F: A
meta-analysis of randomized controlled trials comparing
antibacterial therapy with placebo in Crohn's disease. Colorectal
Dis. 13:617–626. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Thia KT, Mahadevan U, Feagan BG, Wong C,
Cockeram A, Bitton A, Bernstein CN and Sandborn WJ: Ciprofloxacin
or metronidazole for the treatment of perianal fistulas in patients
with Crohn's disease: A randomized, double-blind,
placebo-controlled pilot study. Inflamm Bowel Dis. 15:17–24. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dewint P, Hansen BE, Verhey E, Oldenburg
B, Hommes DW, Pierik M, Ponsioen CI, van Dullemen HM, Russel M, van
Bodegraven AA and van der Woude CJ: Adalimumab combined with
ciprofloxacin is superior to adalimumab monotherapy in perianal
fistula closure in Crohn's disease: A randomised, double-blind,
placebo controlled trial (ADAFI). Gut. 63:292–299. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Present DH, Rutgeerts P, Targan S, Hanauer
SB, Mayer L, van Hogezand RA, Podolsky DK, Sands BE, Braakman T,
DeWoody KL, et al: Infliximab for the treatment of fistulas in
patients with Crohn's disease. N Engl J Med. 340:1398–1405. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sands BE, Anderson FH, Bernstein CN, Chey
WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken
JE, et al: Infliximab maintenance therapy for fistulizing Crohn's
disease. N Engl J Med. 350:876–885. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ochsenkühn T, Göke B and Sackmann M:
Combining infliximab with 6-mercaptopurine/azathioprine for fistula
therapy in Crohn's disease. Am J Gastroenterol. 97:2022–2025. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hanauer SB, Sandborn WJ, Rutgeerts P,
Fedorak RN, Lukas M, MacIntosh D, Panaccione R, Wolf D and Pollack
P: Human anti-tumor necrosis factor monoclonal antibody
(adalimumab) in Crohn's disease: the CLASSIC-I trial.
Gastroenterology. 130:323–333. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sandborn WJ, Rutgeerts P, Enns R, Hanauer
SB, Colombel JF, Panaccione R, D'Haens G, Li J, Rosenfeld MR, Kent
JD and Pollack PF: Adalimumab induction therapy for Crohn disease
previously treated with infliximab: a randomized trial. Ann Intern
Med. 146:829–838. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
El-Gazzaz G, Hull T and Church JM:
Biological immunomodulators improve the healing rate in surgically
treated perianal Crohn's fistulas. Colorectal Dis. 14:1217–1223.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hotokezaka M, Ikeda T, Uchiyama S,
Tsuchiya K and Chijiiwa K: Results of seton drainage and infliximab
infusion for complex anal Crohn's disease. Hepatogastroenterology.
58:1189–1192. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kasparek MS, Glatzle J, Temeltcheva T,
Mueller MH, Koenigsrainer A and Kreis ME: Long-term quality of life
in patients with Crohn's disease and perianal fistulas: Influence
of fecal diversion. Dis Colon Rectum. 50:2067–2074. 2007.
View Article : Google Scholar : PubMed/NCBI
|
